State Street’s Celularity CELU Stock Holding History

State Street’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.6K	Hold	57,830	–	–	﹤0.01%	4092
2026 Q1	$76.9K	Hold	57,830	–	–	﹤0.01%	4072
2025 Q4	$64.2K	Hold	57,830	–	–	﹤0.01%	4119
2025 Q3	$120K	Sell	57,830 -7,600	-12%	-$21.3K	﹤0.01%	4022
2025 Q2	$128K	Hold	65,430	–	–	﹤0.01%	3931
2025 Q1	$113K	Hold	65,430	–	–	﹤0.01%	3948
2024 Q4	$136K	Buy	65,430 +38,800	+146%	+$92.6K	﹤0.01%	3931
2024 Q3	$79.1K	Hold	26,630	–	–	﹤0.01%	4022
2024 Q2	$83.4K	Buy	26,630 +1,700	+7%	+$5.9K	﹤0.01%	4051
2024 Q1	$130K	Hold	24,930	–	–	﹤0.01%	3976
2023 Q4	$61.7K	Hold	24,930	–	–	﹤0.01%	4159
2023 Q3	$55.4K	Buy	24,930 +5,280	+27%	+$19K	﹤0.01%	4259
2023 Q2	$105K	Sell	19,650 -62,911	-76%	-$403K	﹤0.01%	4227
2023 Q1	$512K	Buy	82,561 +1,323	+2%	+$10.6K	﹤0.01%	3739
2022 Q4	$1.05M	Buy	81,238 +20,336	+33%	+$375K	﹤0.01%	3540
2022 Q3	$1.41M	Buy	60,902 +40,405	+197%	+$1.23M	﹤0.01%	3514
2022 Q2	$697K	Buy	+20,497	New	+$1.66M	﹤0.01%	3714

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

State Street's CELU Position: Q2 2026 in Review

State Street held its Celularity (CELU) position steady in Q2 2026 at 57,830 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4092.

State Street first reported a position in CELU in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.41M in Q3 2022. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

State Street held 57,830 shares of Celularity worth $34.6K as of Q2 2026.
State Street left its Celularity share count unchanged in Q2 2026.
Celularity made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4092 holding.
State Street first reported a position in Celularity in Q2 2022 and has held it in 17 quarters since.
State Street's Celularity position peaked at $1.41M in Q3 2022.
39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.